Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 476

Similar articles for PubMed (Select 15289387)

1.

Comparing warfarin with aspirin after biological aortic valve replacement: a prospective study.

Gherli T, Colli A, Fragnito C, Nicolini F, Borrello B, Saccani S, D'Amico R, Beghi C.

Circulation. 2004 Aug 3;110(5):496-500.

2.
3.

Anticoagulation is unnecessary after biological aortic valve replacement.

Moinuddeen K, Quin J, Shaw R, Dewar M, Tellides G, Kopf G, Elefteriades J.

Circulation. 1998 Nov 10;98(19 Suppl):II95-8; discussion II98-9.

PMID:
9852888
4.

Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?

ElBardissi AW, DiBardino DJ, Chen FY, Yamashita MH, Cohn LH.

J Thorac Cardiovasc Surg. 2010 May;139(5):1137-45. doi: 10.1016/j.jtcvs.2009.10.064. Epub 2010 Mar 19.

PMID:
20303508
5.

Cerebral microembolization after bioprosthetic aortic valve replacement: comparison of warfarin plus aspirin versus aspirin only.

Al-Atassi T, Lam K, Forgie M, Boodhwani M, Rubens F, Hendry P, Masters R, Goldstein W, Bedard P, Mesana T, Ruel M.

Circulation. 2012 Sep 11;126(11 Suppl 1):S239-44.

6.

Is early anticoagulation with warfarin necessary after bioprosthetic aortic valve replacement?

Sundt TM, Zehr KJ, Dearani JA, Daly RC, Mullany CJ, McGregor CG, Puga FJ, Orszulak TA, Schaff HV.

J Thorac Cardiovasc Surg. 2005 May;129(5):1024-31.

PMID:
15867776
7.

Antiplatelet therapy early after bioprosthetic aortic valve replacement is unnecessary in patients without thromboembolic risk factors.

Brueck M, Kramer W, Vogt P, Steinert N, Roth P, Görlach G, Schönburg M, Heidt MC.

Eur J Cardiothorac Surg. 2007 Jul;32(1):108-12. Epub 2007 Apr 20.

PMID:
17449264
8.

High risk of thromboemboli early after bioprosthetic cardiac valve replacement.

Heras M, Chesebro JH, Fuster V, Penny WJ, Grill DE, Bailey KR, Danielson GK, Orszulak TA, Pluth JR, Puga FJ, et al.

J Am Coll Cardiol. 1995 Apr;25(5):1111-9.

9.

Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database.

Brennan JM, Edwards FH, Zhao Y, O'Brien S, Booth ME, Dokholyan RS, Douglas PS, Peterson ED; DEcIDE AVR Research Team.

J Am Coll Cardiol. 2012 Sep 11;60(11):971-7. doi: 10.1016/j.jacc.2012.05.029. Epub 2012 Aug 22.

10.

Comparison of anticoagulation regimens after Carpentier-Edwards aortic or mitral valve replacement.

Blair KL, Hatton AC, White WD, Smith LR, Lowe JE, Wolfe WG, Young WG, Oldham HN, Douglas JM Jr, Glower DD.

Circulation. 1994 Nov;90(5 Pt 2):II214-9.

PMID:
7955256
11.

Is early antithrombotic therapy necessary after tissue mitral valve replacement?

Colli A, D'Amico R, Mestres CA, Pomar JL, Cámara ML, Ruyra X, Mulet J.

J Heart Valve Dis. 2010 Jul;19(4):405-11.

PMID:
20845885
12.

Low-intensity oral anticoagulant plus low-dose aspirin during the first six months versus standard-intensity oral anticoagulant therapy after mechanical heart valve replacement: a pilot study of low-intensity warfarin and aspirin in cardiac prostheses (LIWACAP).

Pengo V, Palareti G, Cucchini U, Molinatti M, Del Bono R, Baudo F, Ghirarduzzi A, Pegoraro C, Iliceto S; participating centers of Italian Federation of Anticoagulation Clinics (FCSA).

Clin Appl Thromb Hemost. 2007 Jul;13(3):241-8.

PMID:
17636186
13.

Comparative study of warfarin versus antiplatelet therapy in patients with a St. Jude Medical valve in the aortic position.

Hartz RS, LoCicero J 3rd, Kucich V, DeBoer A, O'Mara S, Meyers SN, Michaelis LL.

J Thorac Cardiovasc Surg. 1986 Oct;92(4):684-90.

PMID:
3762199
14.

Late incidence and determinants of stroke after aortic and mitral valve replacement.

Ruel M, Masters RG, Rubens FD, Bédard PJ, Pipe AL, Goldstein WG, Hendry PJ, Mesana TG.

Ann Thorac Surg. 2004 Jul;78(1):77-83; discussion 83-4.

PMID:
15223407
15.

Aortic valve replacement: a prospective randomized evaluation of mechanical versus biological valves in patients ages 55 to 70 years.

Stassano P, Di Tommaso L, Monaco M, Iorio F, Pepino P, Spampinato N, Vosa C.

J Am Coll Cardiol. 2009 Nov 10;54(20):1862-8. doi: 10.1016/j.jacc.2009.07.032.

16.

Antiplatelet therapy in patients receiving aortic bioprostheses: a report of clinical and instrumental safety.

di Marco F, Grendene S, Feltrin G, Meneghetti D, Gerosa G.

J Thorac Cardiovasc Surg. 2007 Jun;133(6):1597-603.

PMID:
17532962
17.

Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Whitlock RP, Sun JC, Fremes SE, Rubens FD, Teoh KH; American College of Chest Physicians.

Chest. 2012 Feb;141(2 Suppl):e576S-600S. doi: 10.1378/chest.11-2305.

18.
19.

Anticoagulation or antiplatelet therapy of bioprosthetic heart valves recipients: an unresolved issue.

Colli A, Verhoye JP, Leguerrier A, Gherli T.

Eur J Cardiothorac Surg. 2007 Apr;31(4):573-7. Epub 2007 Feb 21. Review.

PMID:
17317197
20.

Antiplatelet therapy in children with left-sided mechanical prostheses.

LeBlanc JG, Sett SS, Vince DJ.

Eur J Cardiothorac Surg. 1993;7(4):211-5.

PMID:
8481259
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk